Editor’s Note
**Editor’s Note:** Amorepacific Holdings has entered into a strategic investment agreement with Higher Corporation, a specialist in dermatological beauty medical devices, to deepen collaboration across the beauty and medical sectors. The partnership aims to drive next-generation solutions by merging Higher’s expertise in aesthetic device development and medical research with Amorepacific’s industry strengths.
Amorepacific Holdings announced on the 27th that it has signed an investment agreement with Higher Corporation, a specialized company in dermatological beauty medical devices, to strengthen collaboration in the beauty and medical fields.
Through this agreement, both companies will actively pursue the development of next-generation beauty and medical solutions. They plan to combine Higher Corporation’s capabilities in aesthetic medical device development, joint research with medical professionals, and global KOL network with Amorepacific’s skin science research and skincare technology to collaborate across product planning, R&D, distribution, and marketing.
As part of this agreement, Amorepacific Holdings has made a strategic investment in Higher Corporation, further solidifying their mid-to-long-term cooperative relationship.
Based on this contract, the two companies will advance the development and commercialization of skin beauty products including skin boosters, cosmeceuticals, and medical devices; develop post-procedure aftercare products and collaborate on distribution to hospitals and clinics; and engage in joint R&D of raw materials and ingredients as well as marketing activities.
In particular, by combining Higher Corporation’s medical professional network and expertise in the aesthetic market with Amorepacific’s skin research capabilities and brand assets, they plan to develop integrated solutions that connect professional treatment areas with daily skincare.
